Mike Matson
Stock Analyst at Needham
(3.07)
# 1,329
Out of 5,012 analysts
537
Total ratings
42.37%
Success rate
1.19%
Average return
Main Sectors:
Stocks Rated by Mike Matson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BSX Boston Scientific | Reiterates: Buy | $121 | $95.90 | +26.17% | 33 | Oct 1, 2025 | |
| LIVN LivaNova | Reiterates: Buy | $64 | $52.15 | +22.72% | 27 | Sep 3, 2025 | |
| NEO NeoGenomics | Maintains: Buy | $8 → $14 | $9.03 | +55.04% | 27 | Aug 29, 2025 | |
| TMDX TransMedics Group | Reiterates: Hold | n/a | $115.18 | - | 12 | Aug 25, 2025 | |
| AORT Artivion | Maintains: Buy | $45 → $50 | $40.51 | +23.43% | 19 | Aug 22, 2025 | |
| IMDX Insight Molecular Diagnostics | Reiterates: Buy | $4.25 | $3.68 | +15.49% | 1 | Aug 18, 2025 | |
| MDT Medtronic | Reiterates: Hold | n/a | $98.33 | - | 21 | Aug 14, 2025 | |
| LUCD Lucid Diagnostics | Reiterates: Buy | $3 | $1.05 | +185.71% | 21 | Aug 13, 2025 | |
| HAE Haemonetics | Maintains: Buy | $84 → $68 | $49.26 | +38.04% | 14 | Aug 7, 2025 | |
| ENOV Enovis | Maintains: Buy | $57 → $49 | $30.33 | +61.56% | 16 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $442 → $448 | $369.24 | +21.33% | 9 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $15.03 | - | 20 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $44 → $45 | $34.13 | +31.85% | 35 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $108 | $82.70 | +30.59% | 30 | Jul 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $48 | $40.43 | +18.72% | 3 | Jun 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $61 | $45.90 | +32.90% | 25 | Jun 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $67.73 | - | 21 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $12 | $8.59 | +39.70% | 19 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $42 | $18.07 | +132.43% | 23 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $51 → $41 | $34.61 | +18.46% | 17 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $28.82 | - | 21 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $150.25 | - | 25 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $7.57 | -7.53% | 20 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $118.10 | - | 5 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $241.56 | - | 11 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $126.89 | - | 9 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $249.04 | - | 10 | Feb 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $99.06 | - | 26 | Feb 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $283.28 | - | 14 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $42 | $15.33 | +173.97% | 2 | May 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $65 → $75 | $59.31 | +26.45% | 1 | Feb 18, 2021 |
Boston Scientific
Oct 1, 2025
Reiterates: Buy
Price Target: $121
Current: $95.90
Upside: +26.17%
LivaNova
Sep 3, 2025
Reiterates: Buy
Price Target: $64
Current: $52.15
Upside: +22.72%
NeoGenomics
Aug 29, 2025
Maintains: Buy
Price Target: $8 → $14
Current: $9.03
Upside: +55.04%
TransMedics Group
Aug 25, 2025
Reiterates: Hold
Price Target: n/a
Current: $115.18
Upside: -
Artivion
Aug 22, 2025
Maintains: Buy
Price Target: $45 → $50
Current: $40.51
Upside: +23.43%
Insight Molecular Diagnostics
Aug 18, 2025
Reiterates: Buy
Price Target: $4.25
Current: $3.68
Upside: +15.49%
Medtronic
Aug 14, 2025
Reiterates: Hold
Price Target: n/a
Current: $98.33
Upside: -
Lucid Diagnostics
Aug 13, 2025
Reiterates: Buy
Price Target: $3
Current: $1.05
Upside: +185.71%
Haemonetics
Aug 7, 2025
Maintains: Buy
Price Target: $84 → $68
Current: $49.26
Upside: +38.04%
Enovis
Aug 7, 2025
Maintains: Buy
Price Target: $57 → $49
Current: $30.33
Upside: +61.56%
Aug 1, 2025
Maintains: Buy
Price Target: $442 → $448
Current: $369.24
Upside: +21.33%
Jul 30, 2025
Reiterates: Hold
Price Target: n/a
Current: $15.03
Upside: -
Jul 30, 2025
Maintains: Buy
Price Target: $44 → $45
Current: $34.13
Upside: +31.85%
Jul 18, 2025
Reiterates: Buy
Price Target: $108
Current: $82.70
Upside: +30.59%
Jun 13, 2025
Reiterates: Buy
Price Target: $48
Current: $40.43
Upside: +18.72%
Jun 12, 2025
Downgrades: Hold
Price Target: $61
Current: $45.90
Upside: +32.90%
May 28, 2025
Reiterates: Hold
Price Target: n/a
Current: $67.73
Upside: -
May 22, 2025
Upgrades: Buy
Price Target: $12
Current: $8.59
Upside: +39.70%
May 8, 2025
Reiterates: Buy
Price Target: $42
Current: $18.07
Upside: +132.43%
May 8, 2025
Maintains: Buy
Price Target: $51 → $41
Current: $34.61
Upside: +18.46%
Apr 30, 2025
Reiterates: Hold
Price Target: n/a
Current: $28.82
Upside: -
Apr 10, 2025
Reiterates: Hold
Price Target: n/a
Current: $150.25
Upside: -
Apr 10, 2025
Reiterates: Buy
Price Target: $7
Current: $7.57
Upside: -7.53%
Apr 8, 2025
Reiterates: Hold
Price Target: n/a
Current: $118.10
Upside: -
Apr 7, 2025
Reiterates: Hold
Price Target: n/a
Current: $241.56
Upside: -
Mar 12, 2025
Reiterates: Hold
Price Target: n/a
Current: $126.89
Upside: -
Feb 19, 2025
Reiterates: Hold
Price Target: n/a
Current: $249.04
Upside: -
Feb 7, 2025
Reiterates: Hold
Price Target: n/a
Current: $99.06
Upside: -
Jan 31, 2025
Reiterates: Hold
Price Target: n/a
Current: $283.28
Upside: -
May 4, 2021
Maintains: Buy
Price Target: $34 → $42
Current: $15.33
Upside: +173.97%
Feb 18, 2021
Maintains: Buy
Price Target: $65 → $75
Current: $59.31
Upside: +26.45%